Citizens Reiterates Market Outperform on CareTrust REIT, Maintains $44 Price Target
Benzinga Newsdesk 19 hours ago
Analyst RatingsNewsReiterationPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Citizens analyst Aaron Hecht reiterates CareTrust REIT (NYSE:CTRE) with a Market Outperform and maintains $44 price target.
Citizens analyst Aaron Hecht reiterates CareTrust REIT (NYSE:CTRE) with a Market Outperform and maintains $44 price target.
